Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01563679 · ClinicalTrials.gov registry record
Analysis of Percutaneous Ablations for Cancer Treatment
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 26
- Enrollment target
NCT01563679 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 26 participants.
The verdict
NCT01563679 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
This is a study involving patients with cancer who are referred by their treating physician for percutaneous locoregional therapies. Patient's clinical and radiology findings, pathology findings, survival, treatment responses, and complications after their locoregional therapy will be studied.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2012-02 |
| Est. Completion | 2014-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01563679
The ClinicalTrials.gov registry entry for NCT01563679 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01563679 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01563679 about?
NCT01563679 is a clinical study titled "Analysis of Percutaneous Ablations for Cancer Treatment". This is a study involving patients with cancer who are referred by their treating physician for percutaneous locoregional therapies. Patient's clinical and radiology findings, pathology findings, survival, treatment responses, and complications after their locoregional therapy will be studied.
What is the current status of trial NCT01563679?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2012-02. Estimated completion is 2014-01.
Who is sponsoring clinical trial NCT01563679?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.